Arena Pharmaceuticals, Inc. Accounts Receivable
Arena Pharmaceuticals, Inc. had Accounts Receivable of $268.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2020-05-07
- 2020-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $268.00K.
- 2019-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.65M.
- 2019-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.70M.
- 2019-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.82M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2020-03-31 | $268.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.65M 10-Q · filed 2020-05-07 | |
| 2019-09-30 | $1.70M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.82M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $3.08M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $5.09M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $1.33M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.33M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $3.31M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $2.36M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $2.37M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $2.40M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.68M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $573.00K 10-K · filed 2018-03-14 | $20.16M 10-K · filed 2017-03-15 |
| 2016-09-30 | $18.30M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $3.34M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $6.17M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $4.93M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $3.51M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $4.19M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $12.21M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $3.71M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $2.91M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $7.35M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $1.55M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $10.60M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $12.38M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.10M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $1.48M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $5.56M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $672.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $20.58M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $1.00M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $607.00K 10-K · filed 2013-03-01 | |
| 2011-09-30 | $2.02M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $2.02M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $3.50M 10-K · filed 2012-03-15 |